Call For A Free Consultation 24/7 - Se Habla Español

New Low-Testosterone Warnings from the FDA?

Due to some new concerns about testosterone treatments, the US Food and Drug Administration (FDA) is meeting to discuss if further warnings need to be added to low-testosterone treatment medications. The FDA has already added warnings to testosterone replacement drugs because they can cause blood clots.

The warnings had to be updated after loads of lawsuits were filed. The original warnings claimed that blood clots could only form if a person already had an abnormally high red blood cell count. However, the lawsuits proved that people were getting blood clots that had normal red blood cell counts.

This new meeting is to determine if testosterone-replacement therapy can have adverse effects on the cardiovascular system regardless of the person's pre-existing medical history. The FDA also plans on determining the appropriate persons that should take testosterone-replacement medications.

Health Canada joined the discussion encouraging further investigation saying that their investigations have found that serious life-threatening conditions can arise from testosterone-replacement therapies.

If you or a loved one has suffered from taking testosterone-replacement drugs, please contact Kalfus & Nachman. Our experienced Norfolk defective product lawyers can help you get the settlement you deserve. We serve clients in all of Virginia and Northest North Carolina. Call us today at (855) 880-8163.


How We Are Different

  • You Will Pay No Fees Unless We Win Your Case
  • We Have Recovered Millions of Dollars for Our Clients
  • Our Attorneys Are Well-Equipped to Fight Insurance Companies
  • We Have Successfully Handled Thousands of Cases Since 1979
  • We are a Full-Service Firm with Multiple Locations
  • Se Habla Español

Free Case Review

Fill out the form below to get started.
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.